Recent Quotes

My Watchlist

Indicators

Catalent, Inc. Common Stock (NY: CTLT )

63.48 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EST, Dec 17, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	63.48
Bid (Size)	63.00 (1)
Ask (Size)	63.50 (108)
Prev. Close	63.48
Today's Range	63.48 - 63.48
52wk Range	42.11 - 63.49
Shares Outstanding	170,341,553
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Lennox To Join S&P 500 Index, Replacing Catalent

December 18, 2024

Lennox, an AI cooling play, will join the S&P 500 before the open on Dec. 23. Bill Holdings will take its pace in the S&P Midcap 400.

Via Investor's Business Daily

Novo Holdings Completes Acquisition of Catalent

December 18, 2024

From Catalent, Inc.

Via Business Wire

Performance

YTD	+40.91%	+40.91%
1 Month	+6.40%	+6.40%
3 Month	+6.24%	+6.24%
6 Month	+12.41%	+12.41%
1 Year	+44.01%	+44.01%

More News

Ozempic Maker Novo Nordisk Invests Over $1 Billion In New Denmark Production Facility, Closer To Add 3 More From Catalent

December 16, 2024

Via Benzinga

Catalent and Novo Holdings Fulfill All Regulatory Closing Conditions for Pending Transaction

December 14, 2024

From Catalent, Inc.

Via Business Wire

Catalent and Novo Holdings Receive European Commission Unconditional Approval for Pending Transaction

December 06, 2024

From Catalent, Inc.

Via Business Wire

The Weight-Loss Battle That Could Rattle Eli Lilly's $100 Billion Market

December 05, 2024

Via Investor's Business Daily

Catalent, Inc. Reports First Quarter Fiscal 2025 Results

November 05, 2024

From Catalent, Inc.

Via Business Wire

Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition

October 23, 2024

Via Benzinga

Catalent Issues Open Letter to Customers Regarding Pending Acquisition by Novo Holdings

October 21, 2024

From Catalent, Inc.

Via Business Wire

After US Senator, Unions Urge Federal Trade Commission To Block Novo's $16.5B Acquisition Of Catalent

October 18, 2024

Via Benzinga

Jim Cramer: 'We Need More Uranium,' Recommends This Stock; Says Novo Nordisk 'Doesn't Hold A Candle' To Big Pharma Rival

October 15, 2024

Via Benzinga

Catalent Signs Agreement to Sell Somerset, NJ Oral Solids Facility

October 14, 2024

From Catalent, Inc.

Via Business Wire

FTC Faces Pressure to Block Novo Nordisk-Catalent Merger Over Antitrust Fears

October 10, 2024

Via Benzinga

Four Stocks To Watch This Week - Tuesday, Oct. 01

October 01, 2024

Via Talk Markets

Tempus AI Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating

September 16, 2024

Via Investor's Business Daily

Catalent, Inc. Reports Fourth Quarter and Fiscal 2024 Results

August 29, 2024

From Catalent, Inc.

Via Business Wire

Prediction: Up 74% So Far This Year, This Weight Loss Stock Is About to Crater

August 16, 2024

Via The Motley Fool

Catalent Completes $25 Million Expansion of its Clinical Supply Facility in Schorndorf, Germany

July 16, 2024

From Catalent, Inc.

Via Business Wire

Sarepta's Expanded Approval Unlikely To Influence Novo Holdings' Acquisition of Catalent, But Provides Investor Protection Amid Uncertainty

June 21, 2024

Via Benzinga

S&P 500 Giants Lead Five Healthy Stocks Near Buy Points

June 01, 2024

Via Investor's Business Daily

Catalent Stockholders Approve Transaction with Novo Holdings

May 29, 2024

From Catalent, Inc.

Via Business Wire

Soaring Eli Lilly Stock Could Climb Another 24% According to a Wall Street Analyst. Is the Stock a Buy Now?

May 28, 2024

Via The Motley Fool

Hedge Funds Tweak Portfolios In Q1: Marvell, TD Synnex, AES Get More Love As Focus Shifts To AI

May 24, 2024

Via Benzinga

CTLT Stock Earnings: Catalent Misses EPS, Misses Revenue for Q3 2024

May 09, 2024

Via InvestorPlace

Catalent, Inc. Reports Third Quarter Fiscal 2024 Results

May 08, 2024

From Catalent, Inc.

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.